214 related articles for article (PubMed ID: 31864665)
1. [Stereotactic body radiotherapy: Passing fad or revolution?].
Vallard A; Vial N; Jmour O; Rehailia-Blanchard A; Trone JC; Sotton S; Daguenet E; Guy JB; Magné N
Bull Cancer; 2020 Feb; 107(2):244-253. PubMed ID: 31864665
[TBL] [Abstract][Full Text] [Related]
2. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
3. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Choi SH; Seong J
Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
Doi H; Beppu N; Kitajima K; Kuribayashi K
Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic tumors and radiotherapy].
Rio E; Mornex F; Peiffert D; Huertas A
Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review.
Rodríguez Plá M; Dualde Beltrán D; Ferrer Albiach E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769050
[No Abstract] [Full Text] [Related]
10. [Extracranial stereotaxic body irradiation: preliminary results and the Orleans hospital experience].
Wachter T; Bouscayrol H; Champeaux E; Verrelle P; Giraud P
Bull Cancer; 2008 Jan; 95(1):153-60. PubMed ID: 18230582
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for metastases to the kidney in patients with non-small cell lung cancer: a new treatment paradigm for durable palliation.
Verma V; Simone CB
Ann Palliat Med; 2017 Apr; 6(2):96-103. PubMed ID: 28480719
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
13. Review and uses of stereotactic body radiation therapy for oligometastases.
Alongi F; Arcangeli S; Filippi AR; Ricardi U; Scorsetti M
Oncologist; 2012; 17(8):1100-7. PubMed ID: 22723509
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
[TBL] [Abstract][Full Text] [Related]
16. [Hypofractionated stereotactic body radiation therapy for adrenal metastases].
Dupic G; Biau J; Bellière-Calandry A; Lapeyre M
Cancer Radiother; 2017 Aug; 21(5):404-410. PubMed ID: 28684242
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
[No Abstract] [Full Text] [Related]
18. [Stereotactic body radiotherapy].
Okabe T; Kimura T; Nagata Y
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2543-5. PubMed ID: 25596046
[TBL] [Abstract][Full Text] [Related]
19. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
20. [Inter- and intrafraction imaging during stereotactic body radiation therapy: Which solutions for which tumours?].
Gensanne D; Hadj Henni A; Lauzin Y; Clarisse P; Thureau S
Cancer Radiother; 2019 Dec; 23(8):891-895. PubMed ID: 31615729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
